These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23497271)

  • 1. Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews.
    Bishop D; Lexchin J
    BMC Health Serv Res; 2013 Mar; 13():88. PubMed ID: 23497271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage with evidence development for pharmaceuticals: a policy in evolution?
    Lexchin J
    Int J Health Serv; 2011; 41(2):337-54. PubMed ID: 21563627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage with evidence development: an examination of conceptual and policy issues.
    Hutton J; Trueman P; Henshall C
    Int J Technol Assess Health Care; 2007; 23(4):425-32. PubMed ID: 17937829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of evidence to guide decision-making during the COVID-19 pandemic: divergent perspectives from a qualitative case study in British Columbia, Canada.
    Brubacher LJ; Lovato CY; Sriram V; Cheng M; Berman P
    Health Res Policy Syst; 2024 Jun; 22(1):66. PubMed ID: 38831457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'The problem is small enough, the problem is big enough': a qualitative study of health technology assessment and public policy on drug funding decisions for children.
    Denburg AE; Giacomini M; Ungar WJ; Abelson J
    Int J Equity Health; 2020 Mar; 19(1):45. PubMed ID: 32228588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evidence-policy divide: a 'critical computational linguistics' approach to the language of 18 health agency CEOs from 9 countries.
    Bell E; Seidel BM
    BMC Public Health; 2012 Oct; 12(1):932. PubMed ID: 23110541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Political Architecture And Legal Framework Related To Social Health Protection Schemes In Pakistan: Qualitative Inquiry Of Policy Makers' Viewpoint.
    Khan SA; Ayub A; Khan KA; Khan RS; Jamil A
    J Ayub Med Coll Abbottabad; 2018; 30(3):389-396. PubMed ID: 30465372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
    Williams I; McIver S; Moore D; Bryan S
    Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces.
    Morgan SG; Thomson PA; Daw JR; Friesen MK
    BMC Health Serv Res; 2013 Jan; 13():34. PubMed ID: 23363626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Politics, policies and processes: a multidisciplinary and multimethods research programme on policies on the social determinants of health inequity in Australia.
    Baum F; Friel S
    BMJ Open; 2017 Dec; 7(12):e017772. PubMed ID: 29273655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage options for promising technologies: Medicare's 'coverage with evidence development'.
    Tunis SR; Pearson SD
    Health Aff (Millwood); 2006; 25(5):1218-30. PubMed ID: 16966717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical challenges related to elder care. High level decision-makers' experiences.
    Mamhidir AG; Kihlgren M; Sorlie V
    BMC Med Ethics; 2007 Apr; 8():3. PubMed ID: 17419880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives.
    Vickery J; Atkinson P; Lin L; Rubin O; Upshur R; Yeoh EK; Boyer C; Errett NA
    BMJ Glob Health; 2022 Apr; 7(4):. PubMed ID: 35450862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaling up population health interventions from decision to sustainability - a window of opportunity? A qualitative view from policy-makers.
    Lee K; van Nassau F; Grunseit A; Conte K; Milat A; Wolfenden L; Bauman A
    Health Res Policy Syst; 2020 Oct; 18(1):118. PubMed ID: 33036633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage with evidence development: the Ontario experience.
    Levin L; Goeree R; Levine M; Krahn M; Easty T; Brown A; Henry D
    Int J Technol Assess Health Care; 2011 Apr; 27(2):159-68. PubMed ID: 21473814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the usefulness of budget impact analyses: a U.S. payer perspective.
    Watkins JB; Danielson D
    Value Health; 2014; 17(1):3-4. PubMed ID: 24438711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.